NO954323L - Heterocykliske derivater - Google Patents
Heterocykliske derivaterInfo
- Publication number
- NO954323L NO954323L NO954323A NO954323A NO954323L NO 954323 L NO954323 L NO 954323L NO 954323 A NO954323 A NO 954323A NO 954323 A NO954323 A NO 954323A NO 954323 L NO954323 L NO 954323L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- alkylcarbamoyl
- carbamoyl
- alkoxycarbonyl
- alkoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Forbindelser med formel (I) hvor R1 er hydrogen eller hydroksy; R2 er hydrogen; eller R1 og R2 er forbundet slik at CR^CR2 er en dobbeltbinding; X er valgt fra -CH2CH2-, -CH=CH-, -C=C-, -CH20-, -OCH2-, -CH2NH-, -NHCH2-, -CH2CO-, -COCH2/ - . CH2S(O)n- og -S(O)nCH2- (hvor n er O, l eller 2); Ar er en ; fenylgruppe som bærer en eller flere substituenter uavhengig av hverandre valgt fra gruppene (l-6C)alkyl, (2-6C)alkenyl, (2-6C)alkynyl, (1-6C)alkoksy, (1-6C)alkoksykarbonyl, (1-6C)- alkoksykarbonyl(l-6C)alkyl, (1-6C)alkoksy(l-6C)alkyl, (1- 6C)alkylamino, di-[(1-6C)alkyl]amino, karbamoyl, (1-6C)alkyl- karbamoyl, di-[(1-6C)alkyl]karbamoyl, (1-6C)alkanoyl og deres oksimderivater, og O-(1-6C)alkyletere av nevnte oksimer, (1- GOalkyltio, (1-6C) alkylsulf inyl og (1-6C) alkylsulfonyl når substituert med en eller flere grupper valgt fra (1-6C)- alkoksykarbonyl, (1-6C)alkanoyl og deres oksimderivater, og O- (1-6C)alkyletere av nevnte oksimderivater, (1-6C)alkanoyl- amino, (1-6C)alkanoyloksy, (1-6C)alkanoyloksy(1-6C)alkyl, ¿karbamoyl, N-(1-6C)alkylkarbamoyl, N,N-di[(1-6C)alkyl- 'karbamoyl, amino, (1-6C)alkylamino, di-[(1-6C)alkyl]amino, (1- i 6C)alkoksy, (2-6C)alkenyloksy, (1-6C)alkyltio, (1-6C)alkyl- i sulfinyl, (1-6C)alkylsulfonyl, halogen(1-6C)alkyl, (2-6C)- | alkenyl, (2-6C)alkynyl, fenyl, fenoksy, cyano, nitro, hydroksy l og karboksy; og hvor Ar kan bære ytterligere substituenter; og | deres farmasøytisk akseptable salter som hemmer skvalensyntese og følgelig kan brukes for å senke cholesterolnivået i blod- plasma. Det er også beskrevet fremgangsmåter for fremstilling av forbindelser med formel I så vel som farmasøytiske preparater som inneholder disse forbindelser, og deres anvendelse i medisin.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939308842A GB9308842D0 (en) | 1993-04-29 | 1993-04-29 | Heterocyclic derivatives |
GB939324813A GB9324813D0 (en) | 1993-12-03 | 1993-12-03 | Heterocyclic compounds |
GB9402127A GB9402127D0 (en) | 1994-02-04 | 1994-02-04 | Heterocyclic derivatives |
PCT/GB1994/000910 WO1994025459A1 (en) | 1993-04-29 | 1994-04-28 | Heterocyclic derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
NO954323D0 NO954323D0 (no) | 1995-10-27 |
NO954323L true NO954323L (no) | 1995-12-21 |
Family
ID=27266674
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO954323A NO954323L (no) | 1993-04-29 | 1995-10-27 | Heterocykliske derivater |
Country Status (11)
Country | Link |
---|---|
US (1) | US5919793A (no) |
EP (1) | EP0696284A1 (no) |
JP (1) | JPH08509488A (no) |
CN (1) | CN1121718A (no) |
AU (1) | AU6576494A (no) |
CA (1) | CA2160795A1 (no) |
FI (1) | FI955164A0 (no) |
GB (1) | GB9408473D0 (no) |
IL (1) | IL109451A0 (no) |
NO (1) | NO954323L (no) |
WO (1) | WO1994025459A1 (no) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2737721B1 (fr) * | 1995-08-08 | 1997-09-05 | Roussel Uclaf | Nouveaux composes biphenyles, leur procede de preparation et les intermediaires de ce procede, leur application a titre de medicament et les compositions pharmaceutiques les contenant |
EP1217001B1 (en) | 1999-09-28 | 2005-12-07 | Eisai Co., Ltd. | Quinuclidine compounds and drugs containing the same as the active ingredient |
WO2002016357A2 (en) | 2000-08-18 | 2002-02-28 | Pharmacia & Upjohn Company | Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands) |
EP1381603A2 (en) | 2000-08-18 | 2004-01-21 | PHARMACIA & UPJOHN COMPANY | Quinuclidine-substituedaryl moieties for treatment of disease ( nicotinic acetylcholine receptor ligands ) |
DE60220997T2 (de) | 2001-03-27 | 2008-03-13 | Eisai R&D Management Co., Ltd. | N-aryl-substituiertes cyclisches aminderivat und medizin, die dieses als wirkstoff enthält |
PE20021019A1 (es) | 2001-04-19 | 2002-11-13 | Upjohn Co | Grupos azabiciclicos sustituidos |
MXPA04000779A (es) * | 2001-08-24 | 2004-04-20 | Pharmacia & Up John Company | 7-aza[2.2.1]bicicloheptanos sustituidos con arilo para el tratamiento de enfermedades. |
MXPA04007936A (es) | 2002-02-15 | 2004-11-26 | Upjohn Co | Compuestos de aril-sustituidos para el tratamiento de enfermedades. |
TW200305636A (en) * | 2002-04-18 | 2003-11-01 | Merck Patent Gmbh | Polymerisable compounds comprising a cinnamic acid group and an acetylene group |
US7129268B2 (en) * | 2002-10-28 | 2006-10-31 | Novo Nordisk A/S | Peroxisome proliferator activated receptor-active arylene acetic acid derivatives |
EP1745014B1 (en) * | 2004-05-05 | 2011-07-06 | High Point Pharmaceuticals, LLC | Novel compounds, their preparation and use |
ES2347578T3 (es) * | 2004-05-05 | 2010-11-02 | High Point Pharmaceuticals, Llc | Derivados del acido fenoxiacetico como agonistas de ppar. |
WO2007071766A2 (en) | 2005-12-22 | 2007-06-28 | Transtech Pharma | Phenoxy acetic acids as ppar delta activators |
SA08290475B1 (ar) * | 2007-08-02 | 2013-06-22 | Targacept Inc | (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه |
AU2021312855A1 (en) | 2020-07-22 | 2023-03-09 | Reneo Pharmaceuticals, Inc. | Crystalline PPAR-delta agonist |
WO2023147309A1 (en) | 2022-01-25 | 2023-08-03 | Reneo Pharmaceuticals, Inc. | Use of ppar-delta agonists in the treatment of disease |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2067534T3 (es) * | 1988-04-01 | 1995-04-01 | Sankyo Co | Derivados de 2-(heterocicliltio)carbapenemo, su preparacion y su aplicacion como antibioticos. |
YU84791A (sh) * | 1990-05-19 | 1994-06-10 | Boehringer Ingelheim Kg. | Biciklicni 1-aza-cikloalkalni |
WO1992015579A1 (en) * | 1991-03-08 | 1992-09-17 | Rhone-Poulenc Rorer International (Holdings) Inc. | Multicyclic tertiary amine polyaromatic squalene synthetase inhibitors |
US5385912A (en) * | 1991-03-08 | 1995-01-31 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Multicyclic tertiary amine polyaromatic squalene synthase inhibitors |
GB9127279D0 (en) * | 1991-12-23 | 1992-02-19 | Ici Plc | Heterocyclic derivatives |
GB9201749D0 (en) * | 1992-01-28 | 1992-03-11 | Smithkline Beecham Plc | Medicaments |
WO1993021184A1 (en) * | 1992-04-10 | 1993-10-28 | Zeneca Limited | Biphenylylquinuclidine derivatives as squalene synthase inhibitors |
GB9216721D0 (en) * | 1992-08-06 | 1992-09-23 | Ici Plc | Therapeutic heterocyclic derivatives |
GB9218334D0 (en) * | 1992-08-28 | 1992-10-14 | Ici Plc | Heterocyclic compounds |
-
1994
- 1994-04-27 IL IL10945194A patent/IL109451A0/xx unknown
- 1994-04-28 CN CN94191933A patent/CN1121718A/zh active Pending
- 1994-04-28 AU AU65764/94A patent/AU6576494A/en not_active Abandoned
- 1994-04-28 EP EP94913724A patent/EP0696284A1/en not_active Withdrawn
- 1994-04-28 JP JP6524035A patent/JPH08509488A/ja active Pending
- 1994-04-28 CA CA002160795A patent/CA2160795A1/en not_active Abandoned
- 1994-04-28 GB GB9408473A patent/GB9408473D0/en active Pending
- 1994-04-28 US US08/537,827 patent/US5919793A/en not_active Expired - Fee Related
- 1994-04-28 WO PCT/GB1994/000910 patent/WO1994025459A1/en not_active Application Discontinuation
-
1995
- 1995-10-27 FI FI955164A patent/FI955164A0/fi unknown
- 1995-10-27 NO NO954323A patent/NO954323L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JPH08509488A (ja) | 1996-10-08 |
CA2160795A1 (en) | 1994-11-10 |
NO954323D0 (no) | 1995-10-27 |
FI955164A (fi) | 1995-10-27 |
WO1994025459A1 (en) | 1994-11-10 |
AU6576494A (en) | 1994-11-21 |
EP0696284A1 (en) | 1996-02-14 |
FI955164A0 (fi) | 1995-10-27 |
CN1121718A (zh) | 1996-05-01 |
IL109451A0 (en) | 1994-07-31 |
US5919793A (en) | 1999-07-06 |
GB9408473D0 (en) | 1994-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO954323L (no) | Heterocykliske derivater | |
AU2003215753A1 (en) | Imidazopyridine derivatives as kinase inhibitors | |
EP1550662A4 (en) | NEW ADENINE COMPOUND AND ITS USE | |
DE60003001D1 (en) | Pyrimidinverbindungen | |
NO20004624D0 (no) | Benzensulfonamid-derivater og deres anvendelse som medikamenter | |
AU6307290A (en) | Pyrazole derivatives, processes for preparation thereof and pharmaceutical composition comprising the same | |
AU617918B2 (en) | 2-aminopyrimidinone derivatives | |
AU624405B2 (en) | Heterocyclic bisphosphonic acid derivatives | |
TNSN05080A1 (en) | NOVEL ANTIMYCOBACTERIAL COMPOUNDS (as filed) AND PYRROLE DERIVATIVES AS ANTIMYCOBACTERIAL COMPOUNDS (as published) | |
AU622509B2 (en) | 2-aminopyrimidinone derivatives | |
NZ516100A (en) | Streptogramin derivatives, preparation and compositions containing them | |
RU2027435C1 (ru) | Вещество, снижающее внутриглазное давление | |
EP0654032A1 (en) | QUINUCLIDINE DERIVATIVES FOR USE AS SQUALENE SYNTHETASE INHIBITORS. | |
ATE285771T1 (de) | Diaminotrifluoromethylpyrimidinderivate enthaltende antikrebs-zusammensetzung | |
EP1132085A4 (en) | MEDICINAL PRODUCTS AND REAGENTS CONTAIN THE N-ACYLOXYLATED CYCLOALKYL COMPOUNDS AS ACTIVE INGREDIENTS | |
NZ512891A (en) | S-oxide lipid lowering compounds | |
EP1136488A4 (en) | SF2809-I, II, III. VI, V AND VI COMPOUNDS WITH CHYMASE INHIBITING EFFECT | |
DE69320911T2 (de) | Chinuclidine derivate als squalen synthase inhibitore | |
EP1219619A4 (en) | piperidine | |
US5273976A (en) | Ocular hypotensive agents | |
AU5708794A (en) | Quinuclidine derivatives as squalene synthase inhibitors | |
AU3781489A (en) | New benzocycloheptene derivatives, process for the preparation thereof and pharmaceutical compositions containing them | |
NO950408L (no) | Kinuklidinderivater som skvalen-syntase-inhibitorer | |
JO1660B1 (en) | Benzimidazole compounds are a therapeutically effective substitute for chlorine and processes for preparing and using them | |
CA2238723A1 (en) | Arylethenesulfonamide derivatives and drug composition containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |